Search Ontology:
ChEBI
repotrectinib
- Term ID
- CHEBI:229220
- Synonyms
-
- (7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one
- Augtyro
- repotrectinib
- repotrectinibum
- TPX 0005
- TPX-0005
- TPX0005
- Definition
- An azamacrocycle with formula C18H18FN5O2. It is a tyrosine kinase inhibitor (highly potent against ROS1, TRKA-C, and ALK) used for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer.
- References
-
- cas:1802220-02-5
- drugbank:DB16826
- kegg.drug:D11454
- pdb-ccd:7GI
- pubmed:30093503
- pubmed:30188734
- pubmed:31852910
- pubmed:32269053
- pubmed:32278292
- pubmed:34253025
- pubmed:34482287
- pubmed:34625502
- pubmed:34834176
- pubmed:35231576
- pubmed:35334340
- pubmed:35363931
- pubmed:36201110
- pubmed:37262390
- pubmed:37909502
- pubmed:37973688
- pubmed:38047274
- pubmed:38113652
- pubmed:38144536
- pubmed:38197815
- pubmed:38274094
- pubmed:38279972
- pubmed:38322338
- pubmed:38412271
- pubmed:38433235
- wikipedia.en:Repotrectinib
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from repotrectinib
Phenotype where environments contain repotrectinib
Phenotype modified by environments containing repotrectinib
Phenotype affecting repotrectinib
Human Disease Model